1 unchanged sentence
Insider Adoption or Termination of Trading Agreements
−Removed: During the three months ended June 30, 2023, none of our directors or officers informed us of the adoption, amendment, or termination of a “Rule 10b5-1 trading arrangement”
+Added: During the three months ended September 30, 2023, none of our directors or officers informed us of the adoption, amendment, or termination of a “Rule 10b5-1 trading arrangement”
or a “non-Rule 10b5-1 trading agreement”
2 unchanged sentences
Incorporated by Reference
−Removed: Development Line of Credit Agreement, dated as of April 20, 2023 by and between Prime Capital Ventures, LLC and HCW Biologics Inc.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language):
−Removed: (i) the Condensed Balance Sheets as of December 31, 2022 and June 30, 2023 (unaudited);
−Removed: (ii) the Condensed Statements of Operations for the three and six months ended June 30, 2022 (unaudited) and June 30, 2023 (unaudited);
+Added: The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language):
+Added: (i) the Condensed Balance Sheets as of December 31, 2022 and September 30, 2023 (unaudited);
+Added: (ii) the Condensed Statements of Operations for the three and nine months ended September 30, 2022 (unaudited) and September 30, 2023 (unaudited);
(iv) the Condensed Statements of Stockholders’
−Removed: Equity for the six months ended June 30, 2022 (unaudited) and June 30, 2023 (unaudited);
−Removed: (v) the Condensed Statements of Cash Flows for the six months ended June 30, 2022 (unaudited) and June 30, 2023 (unaudited);
+Added: Equity for the nine months ended September 30, 2022 (unaudited) and September 30, 2023 (unaudited);
+Added: (v) the Condensed Statements of Cash Flows for the nine months ended September 30, 2022 (unaudited) and September 30, 2023 (unaudited);
and (vi) the notes to the Condensed Financial Statements (unaudited).
3 unchanged sentences
HCW Biologics Inc.
−Removed: August 11, 2023
+Added: November 14, 2023
Chief Executive Officer
(Principal Executive Officer)
−Removed: August 11, 2023
+Added: November 14, 2023
/s/ Rebecca Byam
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.